PharmaAudioconference: Home

The National Congress on the Future of Pharmaceuticals in Medical Care

An Analysis of the New OIG Model Compliance Guidance for the Pharmaceutical Industry

Wednesday, May 21, 2003

1:00 pm - 2:45 pm (Eastern)
12:00 pm - 1:45 pm (Central)
11:00 am - 12:45 pm (Mountain)
10:00 am - 11:45 am (Pacific)

Sponsored by

Supported by

For future information about The National Congress on the Future of Genomics, Biotechnology and Pharmaceuticals Conference Series, please complete the form below.

SAVE THE FOLLOWING DATES!

PHARMA CONGRESS SPRING 2003:
HHS OIG COMPLIANCE GUIDANCE FOR THE PHARMACEUTICAL INDUSTRY: KEY INSIGHTS FROM REGULATORS AND COMPLIANCE EXPERTS

Monday, June 9, 2003
Omni Shoreham Hotel
Washington, DC

IMPORTANT DOWNLOAD!

PricewaterhouseCoopers Analysis of the OIG Compliance Program Guidance for Pharmaceutical Manufacturers is available.

Click here to download

Featured Faculty

John Bentivoglio, Esq.
Partner, Arnold and Porter
Former Special Counsel for Healthcare Fraud
Chief Privacy Officer, United States Department of Justice
Washington, DC

Douglas Lankler, Esq.
Senior Corporate Counsel
Deputy Corporate Compliance Officer
Pfizer Inc.
New York, NY

Scott Lassman, Esq.
Assistant General Counsel, PhRMA
Washington, DC

Mary Riordan, Esq.
Senior Counsel
Office of Inspector General
Department of health and Human Services
Washington, DC

Brenton Saunders, JD, MBA
Partner, PricewaterhouseCoopers
Past President, Health Care Compliance Association
And Founder and Chair-elect, International Association of Privacy Officers
Washington, DC
(Moderator)